109 related articles for article (PubMed ID: 18580060)
21. [Significance of acute-phase inflammatory reactants as an indicator of prognosis after acute myocardial infarction: which is the most useful predictor?].
Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K
J Cardiol; 2003 Aug; 42(2):49-56. PubMed ID: 12964514
[TBL] [Abstract][Full Text] [Related]
22. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry).
Montalescot G; Dallongeville J; Van Belle E; Rouanet S; Baulac C; Degrandsart A; Vicaut E;
Eur Heart J; 2007 Jun; 28(12):1409-17. PubMed ID: 17412730
[TBL] [Abstract][Full Text] [Related]
23. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
Abbott JD; Ahmed HN; Vlachos HA; Selzer F; Williams DO
Am J Cardiol; 2007 Jul; 100(2):190-5. PubMed ID: 17631068
[TBL] [Abstract][Full Text] [Related]
24. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiovascular mortality in patients with acute coronary syndromes.
Zairis MN; Adamopoulou EN; Manousakis SJ; Lyras AG; Bibis GP; Ampartzidou OS; Apostolatos CS; Anastassiadis FA; Hatzisavvas JJ; Argyrakis SK; Foussas SG;
Atherosclerosis; 2007 Oct; 194(2):397-402. PubMed ID: 16962598
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
[TBL] [Abstract][Full Text] [Related]
26. Multibiomarker analysis in patients with acute myocardial infarction.
Schernthaner C; Lichtenauer M; Wernly B; Paar V; Pistulli R; Rohm I; Jung C; Figulla HR; Yilmaz A; Cadamuro J; Haschke-Becher E; Pernow J; Schulze PC; Hoppe UC; Kretzschmar D
Eur J Clin Invest; 2017 Sep; 47(9):638-648. PubMed ID: 28683166
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes in patients with acute left circumflex/obtuse marginal occlusion presenting with myocardial infarction.
Stribling WK; Kontos MC; Abbate A; Cooke R; Vetrovec GW; Lotun K
J Interv Cardiol; 2011 Feb; 24(1):27-33. PubMed ID: 20958792
[TBL] [Abstract][Full Text] [Related]
28. Reperfusion therapy for acute ST-elevation and non ST-elevation myocardial infarction: what can be achieved in daily clinical practice in unselected patients at an interventional center?
Zahn R; Schweppe F; Zeymer U; Schiele R; Gitt AK; Mark B; Frilling B; Seidl K; Winkler R; Heer T; Schneider S; Senges J
Acute Card Care; 2009; 11(2):92-8. PubMed ID: 19391052
[TBL] [Abstract][Full Text] [Related]
29. A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses?
Polonski L; Gasior M; Gierlotka M; Osadnik T; Kalarus Z; Trusz-Gluza M; Zembala M; Wilczek K; Lekston A; Zdrojewski T; Tendera M;
Int J Cardiol; 2011 Oct; 152(1):70-7. PubMed ID: 20684999
[TBL] [Abstract][Full Text] [Related]
30. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006.
Rogers WJ; Frederick PD; Stoehr E; Canto JG; Ornato JP; Gibson CM; Pollack CV; Gore JM; Chandra-Strobos N; Peterson ED; French WJ
Am Heart J; 2008 Dec; 156(6):1026-34. PubMed ID: 19032996
[TBL] [Abstract][Full Text] [Related]
31. Incidence and clinical impact of right bundle branch block in patients with acute myocardial infarction: ST elevation myocardial infarction versus non-ST elevation myocardial infarction.
Kleemann T; Juenger C; Gitt AK; Schiele R; Schneider S; Senges J; Darius H; Seidl K;
Am Heart J; 2008 Aug; 156(2):256-61. PubMed ID: 18657654
[TBL] [Abstract][Full Text] [Related]
32. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.
Rached F; Lhomme M; Camont L; Gomes F; Dauteuille C; Robillard P; Santos RD; Lesnik P; Serrano CV; Chapman MJ; Kontush A
Biochim Biophys Acta; 2015 Sep; 1851(9):1254-61. PubMed ID: 26037829
[TBL] [Abstract][Full Text] [Related]
33. Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial).
Cox DA; Stone GW; Grines CL; Stuckey T; Zimetbaum PJ; Tcheng JE; Turco M; Garcia E; Guagliumi G; Iwaoka RS; Mehran R; O'Neill WW; Lansky AJ; Griffin JJ;
Am J Cardiol; 2006 Aug; 98(3):331-7. PubMed ID: 16860018
[TBL] [Abstract][Full Text] [Related]
34. ST deviation pattern and infarct related artery in acute myocardial infarction.
Rott D; Nowatzky J; Teddy Weiss A; Chajek-Shaul T; Leibowitz D
Clin Cardiol; 2009 Nov; 32(11):E29-32. PubMed ID: 19816991
[TBL] [Abstract][Full Text] [Related]
35. Comparison of outcomes after percutaneous coronary intervention among different coronary subsets (stable and unstable angina pectoris and ST-segment and non-ST-segment myocardial infarction).
Loh JP; Pendyala LK; Kitabata H; Torguson R; Omar A; Minha S; Chen F; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2014 Jun; 113(11):1794-801. PubMed ID: 24837256
[TBL] [Abstract][Full Text] [Related]
36. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
[TBL] [Abstract][Full Text] [Related]
37. Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
Shen L; Shah BR; Nam A; Holmes D; Alexander KP; Bhatt DL; Ho PM; Peterson ED; He B; Roe MT
Am Heart J; 2014 Jun; 167(6):840-5. PubMed ID: 24890533
[TBL] [Abstract][Full Text] [Related]
38. Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction.
Canto AJ; Kiefe CI; Goldberg RJ; Rogers WJ; Peterson ED; Wenger NK; Vaccarino V; Frederick PD; Sopko G; Zheng ZJ; Canto JG
Am Heart J; 2012 Apr; 163(4):572-9. PubMed ID: 22520522
[TBL] [Abstract][Full Text] [Related]
39. Quality of care by classification of myocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction.
Roe MT; Parsons LS; Pollack CV; Canto JG; Barron HV; Every NR; Rogers WJ; Peterson ED;
Arch Intern Med; 2005 Jul; 165(14):1630-6. PubMed ID: 16043682
[TBL] [Abstract][Full Text] [Related]
40. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
